Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stop or Go? Tapering antidepressants in pregnancy
NL-OMON44592Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2015
- Countries
- 1
01
Overview
Randomised, open-label trial in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Erasmus MC. Primary endpoint: Risk of relapse of maternal depressive disorder. Planned start Jan 2015; status: not yet recruiting.
02
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NL-OMON44592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44592.